Having a fatty liver means that excess fat has built up inside your liver cells. It’s extremely common, affecting roughly 1.3 billion people worldwide, or about 16% of the global population. In most cases, it develops silently alongside metabolic issues like carrying extra weight, having high blood sugar, or elevated cholesterol. The good news: in its early stages, fatty liver is reversible.
Why Fat Builds Up in the Liver
Your liver normally processes and exports fat, but when more fat flows in than the liver can handle, the excess gets stored inside liver cells as fat droplets. The primary driver for most people is insulin resistance, a condition where your cells stop responding efficiently to insulin. When that happens, your body compensates by producing more insulin, which signals the liver to ramp up fat production and storage.
Research published in PNAS found that certain fat molecules inside these liver droplets were responsible for 64% of the variability in insulin sensitivity across study participants. In other words, the fat buildup and insulin resistance feed each other in a cycle: insulin resistance causes more liver fat, and more liver fat worsens insulin resistance.
Diet plays a role too. High fructose intake, common in sugary drinks and processed foods, directly fuels fat production inside the liver. NIH-funded research showed that fructose triggers enzymes that convert it into fatty deposits, and that inflammation in the liver accelerates this conversion.
The Updated Medical Name
If you’ve seen different names for this condition, you’re not confused. Doctors used to call it nonalcoholic fatty liver disease (NAFLD), but in 2023 the medical community officially renamed it metabolic dysfunction-associated steatotic liver disease, or MASLD. The name change reflects what the condition actually is: a liver problem driven by metabolic factors, not just the absence of alcohol.
To qualify for a MASLD diagnosis, you need fat in the liver plus at least one of five metabolic risk factors: a BMI of 25 or higher, fasting blood sugar at or above 100 mg/dL, blood pressure at or above 130/85, triglycerides at or above 150 mg/dL, or low HDL cholesterol (below 40 mg/dL for men, below 50 for women). Most people with fatty liver meet at least one of these criteria easily.
Why You Probably Don’t Feel Anything
Fatty liver often causes no symptoms at all, which is why many people first hear about it after a routine blood test or imaging scan done for another reason. When symptoms do appear, they tend to be vague: persistent fatigue, a general sense of feeling unwell, or mild discomfort in the upper right area of your abdomen where the liver sits. There’s no sharp pain or obvious warning sign in the early stages, which is part of what makes the condition easy to ignore.
How Fatty Liver Progresses
Not everyone with fat in their liver will develop serious problems. The condition exists on a spectrum with distinct stages, and most people stay in the earliest one.
Simple steatosis is the first stage. Fat is present in the liver, but there’s no significant inflammation or damage. This is the most common form and the easiest to reverse. Between 10% and 25% of people with fatty liver progress to the next stage, called MASH (previously known as NASH), where the fat triggers inflammation and starts damaging liver cells.
Once inflammation takes hold, the liver can begin to scar. Doctors grade scarring on a scale from F0 (no scarring) to F4 (cirrhosis). Mild scarring at F1 or F2 can still be slowed or reversed. Advanced scarring at F3 is harder to undo. F4, or cirrhosis, means the liver is extensively scarred and losing function. At that point, the risk of liver failure and liver cancer rises significantly. The fibrosis stage is the single most important factor in determining long-term outcomes.
The Heart Risk Most People Don’t Know About
Here’s something that surprises many people: the leading cause of death in people with fatty liver disease is not liver failure. It’s heart disease. Fatty liver is now recognized as an independent risk factor for cardiovascular problems, even after accounting for the usual suspects like high blood pressure and cholesterol.
The numbers are striking. A large meta-analysis found that people with fatty liver had a 77% higher risk of developing cardiovascular disease and a 43% higher risk of dying from it. Individual studies have reported even steeper risks, with one finding a hazard ratio of 4.1 for nonfatal cardiovascular events and another showing an odds ratio of 2.31 for significant coronary artery blockages. The American Heart Association now considers fatty liver a “risk enhancer” when evaluating someone’s heart disease risk.
The connection isn’t just statistical. Fatty liver promotes body-wide inflammation, damages blood vessel linings, and encourages fat deposits around other organs, including the heart. Increased fat around the heart correlates with inflammation inside the heart muscle and faster buildup of arterial plaque. Fatty liver has also been linked to higher rates of chronic kidney disease.
How It’s Diagnosed
Most fatty liver is first spotted on an abdominal ultrasound, where the excess fat makes the liver appear brighter than normal. This tells your doctor fat is present but doesn’t reveal how much damage, if any, has occurred.
To assess scarring, doctors often start with a simple blood-based score called the FIB-4 index, calculated from your age, platelet count, and two liver enzymes. A FIB-4 score below 1.3 rules out advanced scarring about 89 to 90% of the time. Scores above 2.67 indicate a high likelihood of significant fibrosis. If your score falls in the uncertain middle range, the next step is typically a specialized imaging test that measures liver stiffness, such as transient elastography (often called a FibroScan) or MRI-based elastography. These painless scans can estimate your fibrosis stage without a needle biopsy.
Reversing Fatty Liver
Weight loss is the most effective treatment. Losing just 3 to 5% of your body weight is typically enough for fat to start disappearing from the liver. That’s about 6 to 10 pounds for someone who weighs 200 pounds. If inflammation or scarring has already developed, a greater weight loss of around 10% of body weight is needed to improve those more advanced changes.
How you lose weight matters less than losing it. A combination of reduced calorie intake and regular physical activity works for most people. Cutting back on added sugars, particularly fructose from sweetened beverages, directly reduces one of the pathways that feeds liver fat production. A Mediterranean-style eating pattern, rich in vegetables, whole grains, fish, and olive oil, has shown consistent benefits in studies of liver fat reduction.
Exercise helps even without weight loss. Regular physical activity improves insulin sensitivity, which slows the cycle of fat accumulation in the liver. Both aerobic exercise (walking, cycling, swimming) and resistance training have demonstrated benefits.
Medication Options
For decades, there were no approved drugs specifically for fatty liver disease. That changed in March 2024, when the FDA approved the first medication for adults with MASH who have moderate to advanced liver scarring (stages F2 and F3) but have not yet progressed to cirrhosis. The drug, called Rezdiffra (resmetirom), works by activating a thyroid hormone receptor in the liver that helps clear fat and reduce inflammation. It’s approved for use alongside diet and exercise, not as a replacement for lifestyle changes.
This medication is specifically for people with confirmed MASH and significant scarring. If you have simple fatty liver without inflammation or fibrosis, lifestyle changes remain the primary treatment and are often all that’s needed to fully reverse the condition.